Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study

1. Ocana, A.
2. Gil-Martin, M.
3. Antolín, S.
4. Atienza, M.
5. Montaño, Á.
6. Ribelles, N.
7. Urruticoechea, A.
8. Falcón, A.
9. Pernas, S.
10. Orlando, J.
11. Montero, J.C.
12. Escudero, M.J.
13. Benito, S.
14. Caballero, R.
15. Carrasco, E.
16. Rojo, F.
17. Pandiella, A.
18. Ruiz-Borrego, M.